Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$0 Sell
12
-176
-94% -$2.23K ﹤0.01% 10372
2014
Q2
$3K Buy
+188
New +$2.44K ﹤0.01% 9802
2014
Q1
Sell
-331
Closed -$6K 10434
2013
Q4
$6K Buy
331
+54
+19% +$964 ﹤0.01% 9414
2013
Q3
$5K Sell
277
-85
-23% -$1.61K ﹤0.01% 9387
2013
Q2
$8K Buy
+362
New +$9.18K ﹤0.01% 8828

Other funds holding BXC

UBS's BXC Position: Q3 2014 in Review

UBS reduced its BlueLinx (BXC) stake by 94% in Q3 2014, selling an estimated $2.23K and leaving 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #10372.

UBS first reported a position in BXC in Q2 2013 and has held it in 5 quarters since. The position peaked at $8K in Q2 2013. 37 funds tracked by Wall St. Rank hold BXC as of Q3 2014.

  • UBS held 12 shares of BlueLinx worth $0 as of Q3 2014.
  • UBS sold 176 BlueLinx shares in Q3 2014, an estimated $2.23K.
  • BlueLinx made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10372 holding.
  • UBS first reported a position in BlueLinx in Q2 2013 and has held it in 5 quarters since.
  • UBS's BlueLinx position peaked at $8K in Q2 2013.
  • 37 funds tracked by Wall St. Rank held BlueLinx as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.